Despite persistent vascular leakage after treatments, our therapeutic VCAM-IL10-LNPs still led to improved motor behavior, confirming that reducing hematoma size is ultimately sufficient to affect changes to acute motor outcome after ICH, even without changes to vascular leakage. Here, IL10 is linked to hematoma.